- Medicine - 18:00 Insecticide lindane causes cancer
- Life Sciences - 17:01 Comment: Research heralds simple computer game that could help you lose weight
- Medicine - 15:05 Stem cell gene therapy developed at UCLA holds promise for eliminating HIV infection
- Environmental Sciences - 15:00 Restored streams take 25 years or longer to recover
- Arts - 14:05 10 ’Star- Spangled’ facts: U-M expert talks Banner myths, baseball and Jimi Hendrix
- History - 14:05 Groundbreaking television coverage of LGBT milestones now online
- Life Sciences - 13:06 UW team programs solitary yeast cells to say ‘hello’ to one another
- Business - 13:00 Is big data still big news?
- Environmental Sciences - 12:01 Complex leases 'a major reason for cold, damp flats'
- Pedagogy - 11:01 Rudd Centre undertakes major evaluation of adoption support programme
- Medicine - 10:03 For women with bipolar disorder, sleep quality affects mood
- Microtechnics - 09:05 Invisibility cloak aspirations inspire new metasurface material
- Business - Jun 30 LiquiGlide slides into consumer space
- Medicine - Jun 30 Study into older people and mental health support »
- Medicine - Jun 29 New UCLA research links vitamin B-12 supplement to pimply skin
New Information on the Waste-Disposal Units of Living Cells
Important new information on one of the most critical protein machines in living cells has been reported by a team of researchers with the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley. The researchers have provided the most detailed look ever at the "regulatory particle" used by the protein machines known as proteasomes to identify and degrade proteins that have been marked for destruction. The activities controlled by this regulatory particle are critical to the quality control of cellular proteins, as well as a broad range of vital biochemical processes, including transcription, DNA repair and the immune defense system.
"Using electron microscopy and a revolutionary new system for protein expression, we have determined at a subnanometer scale the complete architecture, including the relative positions of all its protein components, of the proteasome regulatory particle," says biophysicist Eva Nogales, the research team’s co-principal investigator. "This provides a structural basis for the ability of the proteasome to recognize and degrade unwanted proteins and thereby regulate the amount of any one type of protein that is present in the cell."
Says the team’s other co-principal investigator and corresponding author, biochemist Andreas Martin, "While the biochemical function of many of the proteasome components have been determined, and some subnanometer structures have been identified, it was unclear before now which component goes where and which components interact with one another. Now we have a much better understanding as to how the proteasome machinery works to control cellular processes and this opens the possibility of manipulating proteasome activity for the treatment of cancer and other diseases."
Nogales, who holds appointments with Berkeley Lab, UC Berkeley, and the Howard Hughes Medical Institute, and Martin, who holds appointments with UC Berkeley and the QB3 Institute, are the senior authors of a paper describing this work in the journal Nature. The paper is titled "Complete subunit architecture of the proteasome regulatory particle." Other co-authors were Gabriel Lander, Eric Estrin, Mary Matyskiela and Charlene Bashore.
At any given moment, a human cell typically contains about 100,000 different proteins, with certain proteins being manufactured and others being discarded as needed for the cell’s continued prosperity. Unwanted proteins are tagged with a "kiss-of-death" label in the form of a polypeptide called "ubiquitin." A protein marked with ubiquitin is delivered to any one of the some 30,000 proteasomes in the cell - barrel-shaped complexes which act as waste disposal units that rapidly break-down or degrade the protein. The 2004 Nobel Prize in chemistry was awarded to a trio of scientists who first described the proteasome process, but a lack of structural information has limited the scientific understanding of the mechanics behind this process.
Nogales, an expert on electron microscopy and image analysis, and Martin, who developed the new protein expression system used in this work, combined the expertise of their respective research groups to study the proteasome regulatory particle in yeast. The particle features 19 sub-units that are organized into two sub-complexes, a "lid" and a "base." The lid contains the regulatory elements that identify the ubiquitin tag marking a protein for destruction, and the base features a hexameric ring that pulls the tagged protein inside the chamber of the proteasome barrel where it is degraded.
"The lid consists of nine non-ATPase proteins including ubiquitin receptors that accept properly tagged proteins but prevent a protein not marked for degradation from engaging with the proteasome," Nogales says. "Since degradation is irreversible, it is critical that only ubiquitin-tagged proteins engage the proteasome. Interestingly, the ubiquitin tag has to be removed before the protein can be translocated into the proteasome’s destruction chamber, so the lid also contains de-ubiquitination enzymes that remove the tags after the protein has engaged with the proteasome."
The proteasome regulatory particle’s base contains six distinct AAA+ ATPases that form the hetero-hexameric ring, which serves as the molecular motor of the proteasome.
"We predict that the ATPases use the energy of ATP binding and hydrolysis to exert a pulling force on engaged proteins, unfolding and translocating them through a narrow central pore and into the degradation chamber," Martin says. "The steps in the proteasome process - from protein recognition to de-ubiquitination and degradation have to be very highly coordinated in time and space. Locating all of these components and identifying their relative orientations has been very telling about how the processes are coordinated with each other."
Nogales credits the protein expression system developed by Martin and his research group, in which proteins are expressed and assembled in bacteria, as being critical to the success of this research.
"Until now researchers had to work with purified protein complexes from the cell, which could not be manipulated or modified in any way," she says. "Andy Martin’s new heterologous expression system allows for the manipulation and dissection of protein functions. For our studies it was crucial to generate lid sub-complexes that had one marker at a time in each of the subunits so that we could determine the position of each protein within the lid. With this new system we generated truncations, deletions and fusion constructs that were used to localize individual subunits and delineate their boundaries within the lid."
Last job offers
- Computer Science/Telecom - 30.6
Studiengangleiter/in Digital Ideation (80-100%)
- Medicine/Pharmacology - 25.6
Position in Flow Cytomety
- Architecture - 25.6
Chargé-e de cours HES en architecture
- Life Sciences - 24.6
PhD position in formulations of hyperpolarized gases as imaging agents
- Social Sciences - 23.6
Associate Professeur or Tenure Track Assistant Professor in social politics
- Psychology - 23.6
Professeur-e associé-e ou Professuer-e assistant-e en PTC en psychologie sociale
- Mechanical Engineering - 29.6
Asst. Professor of Neuromuscular Modelling
- Business/Economics - 29.6
Assistant Professorship in Marketing
- Event - 29.6
Professur für Event Engineering
- Education/Continuing Education - 8.6
Professur für Industrial Management
- Business/Economics - 29.6
Professor Dr. Dirk Ifenthaler
- Literature/Linguistics - 29.6
Professur für, Neuere deutsche Literatur mit komparatistischem Schwerpunkt" zum 01.10.2016
- Business/Economics - 26.6
Associate Professor in Accounting and Finance
- Social Sciences - 26.6
Professor of Education and Head of ESRI
- Medicine/Pharmacology - 30.6
Pediatrics-Assistant / Associate Professor
- Medicine/Pharmacology - 29.6
Associate Professor / Professor (Clinical)